Epilepsy Medication Adherence Study

What we are studying

The purpose of this research study is to evaluate patients’ experiences with epilepsy treatment. You will be in the study for about 6 months. You may or may not be asked to complete a survey at different times throughout to relay your experiences with the levetiracetam. Your use of the levetiracetam will be monitored.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • Not Hispanic or Latino
  • Ages 18 - 85

Eligibility Criteria

  • Epilepsy patients at Wake Forest Baptist Health
  • On levetiracetam with or without other anti-epileptic medication

What is involved

  • 2 telephone
  • 4 visits to the study site

Compensation

None

Contact Information

Study Coordinator
Leah Cardwell, MD
Email
lcardwe@wakehealth.edu
Phone
313-790-5469
Principal Investigator
Steven R Feldman, MD,PhD

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.